Final rule 2026-13139
Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of Hyperhidrosis
The Food and Drug Administration (FDA) is classifying the skin patch for treatment of hyperhidrosis into class II (special controls). The special controls that apply to the device type are identified in this order and will be part of the codified language for classification of the skin patch for treatment of hyperhidrosis. We are taking this action because we have determined that classifying the device into class II will provide a reasonable assurance of safety and effectiveness of the device. We believe this action will also enhance patients' access to beneficial innovative devices, in part by reducing regulatory burdens.
Source-supplied record
Document details
- Document number
- 2026-13139
- Published
- Jun 30, 2026
- Effective
- Jun 30, 2026
- Comments close
- Not supplied
- Federal Register citation
- 91 FR 39461
Docket identifiers
- Docket No. FDA-2026-N-6711
CFR references
- Title 21, part 878